WuXi AppTec Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 28,542
Employees
  • Stock Symbol
  • 603259
Stock Symbol
  • Investments
  • 70
  • Share Price
  • $17.94
  • (As of Monday Closing)

WuXi AppTec General Information

Description

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
SHG
Primary Office
  • 288 Fute Zhong Road
  • Waigaoqiao Free Trade Zone
  • Shanghai, 200131
  • China
+86 021 0000 0000

WuXi AppTec Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

WuXi AppTec Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.94 $17.89 $15.30 - $26.69 2.96B 26.3M $0.22

WuXi AppTec Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 68,504,454 48,313,081 21,311,318 12,438,003
Revenue 3,259,935 2,393,453 1,862,934 1,453,254
EBITDA 748,943 647,893 465,718 484,551
Net Income 637,516 428,485 268,401 341,712
Total Assets 8,216,505 7,085,419 4,178,930 3,295,130
Total Debt 667,401 657,184 813,852 53,759
Public Fundamental Data provided by Morningstar, Inc. disclaimer

WuXi AppTec Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore WuXi AppTec‘s full profile, request access.

Request a free trial

WuXi AppTec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and m
Other Healthcare Services
Shanghai, China
28,542 As of 2021
00.000
000000000 00.000

0000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000000
Newton, MA
00000 As of 0000
00.000
000000000

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000 000000000
Hyderabad, India
0000 As of 0000
0000
00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

WuXi AppTec Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parexel International Private Equity-Backed Newton, MA 00000 00.000 000000000
000000 Private Equity-Backed Hyderabad, India 0000 0000 00000000000 0000
00000 Private Equity-Backed Albany, NY 0000 00.000 000000000 00.000
000000000 Formerly VC-backed Beijing, China 00000 00000 000000000 00000
000 000000000 Formerly VC-backed Durham, NC 0000 0000 000000&0 0000
You’re viewing 5 of 24 competitors. Get the full list »

WuXi AppTec Patents

WuXi AppTec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170299491-A1 Use of tumor dissociation reagent in flow cytometry Abandoned 15-Apr-2016 000000000
US-20200116622-A1 Use of tumor dissociation reagent in flow cytometry Pending 15-Apr-2016 000000000
US-8772483-B2 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid Active 05-Nov-2010 0000000000 00
CA-2816963-A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid Abandoned 05-Nov-2010 0000000000
US-20120122904-A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid Granted 05-Nov-2010 C07D403/12 0
To view WuXi AppTec’s complete patent history, request access »

WuXi AppTec Executive Team (23)

Name Title Board Seat Contact Info
Li Ge Chief Executive Officer & Chairman
Ge Li Ph.D Co-Founder, Chairman and Co-Chief Executive Officer
Steve Yang Ph.D Chief Executive Officer & Board Member
Ellis Chu Senior Vice President and Chief Financial Officer
Peter Tong Senior Vice President and Chief Operating Officer
You’re viewing 5 of 23 executive team members. Get the full list »

WuXi AppTec Board Members (8)

Name Representing Role Since
000000 00 00.0 WuXi AppTec Global Chief Investment Officer & Vice Chairman 000 0000
00 00 00.0 WuXi AppTec Co-Founder, Chairman and Co-Chief Executive Officer 000 0000
00 00 WuXi AppTec Chief Executive Officer & Chairman 000 0000
0000 0000 00.0 WuXi AppTec Board Member & Vice President 000 0000
00000 0000 00.0 WuXi AppTec Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

WuXi AppTec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

WuXi AppTec Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore WuXi AppTec‘s full profile, request access.

Request a free trial

WuXi AppTec Investments & Acquisitions (70)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 20-Oct-2021 00000 0000 00000 Drug Discovery
00000000 0000 01-Jun-2021 00000 0000 00000 Biotechnology
00000000 28-May-2021 00000 0000 0000 Discovery Tools (Healthcare)
000000 000000 26-May-2021 00000 0000 0000 Biotechnology
HUIGGENE Therapeutics 17-May-2021 Early Stage VC 000.00 Drug Delivery
You’re viewing 5 of 70 investments and acquisitions. Get the full list »

WuXi AppTec Subsidiaries (5)

Company Name Industry Location Founded
WuXi Clinical Development Services (Shanghai) Co. Decision/Risk Analysis Beijing, China 2013
0000000000 Other Healthcare Services San Diego, CA 0000
000000 Biotechnology Oxford, United Kingdom 0000
000 00000000000000 Pharmaceuticals Shanghai, China 0000
00 00000000000 Drug Discovery Shanghai, China 0000
To view WuXi AppTec’s complete subsidiaries history, request access »

WuXi AppTec Exits (15)

Company Name Exit Date Exit Type Exit Size Status Buyers
00 000000000000 03-Jun-2020 00000 00000 00 00000 Completed
  • 10 buyers
00000 05-Mar-2020 00000 00000 00 00000 Completed
  • 6 buyers
0000000000 02-Mar-2020 00000 00000 00 00000 Completed
  • 10 buyers
000000000 000000 01-Mar-2020 00000 00000 00 0000 Completed
  • 7 buyers
NanoMicro Tech 23-Dec-2019 PE Growth/Expansion 000.00 Completed
  • 5 buyers
You’re viewing 5 of 15 exits. Get the full list »